| Product |
CAS |
Molecular formula |
More |
| 5-Nitroisoquinolin-3-ol |
581813-27-6 |
C9H6N2O3 |
More |
| 3-((Naphthalen-6-yl)methoxy)-5-bromopyridine |
1245644-34-1 |
|
More |
| Potassium (benzyloxymethyl)trifluoroborate |
1027642-25-6 |
C8H9BOF3-.K+ |
More |
| 2-(4-Hydroxypiperidin-1-yl)-2-phenylacetonitrile |
1018437-11-0 |
C13H16N2O |
More |
| 2-(4-Oxopiperidin-1-yl)-2-phenylacetonitrile |
1018337-05-7 |
C13H14N2O |
More |
| 2-(4,4-Difluoropiperidin-1-yl)-2-phenylacetonitrile |
1226998-22-6 |
C13H14N2F2 |
More |
| 2-(4,4-Difluoropiperidin-1-yl)-2-phenylethanamine |
1227040-43-8 |
|
More |
| (((1-Benzyl-1h-1,2,3-triazol-4-yl)methoxy)methyl)trifluoroborate |
898544-66-6 |
|
More |
| 2-Mercapto-5-methoxybenzoic acid |
16807-37-7 |
C8H8O3S |
More |
| 1-[4-(2-methyl-[1,3]dioxolan-2-yl)-butyl]-1H-pyrazol-3-ylamine |
1163253-75-5 |
C11H19N3O2 |
More |
| 1-[4-(2-methyl-[1,3]dioxolan-2-yl)-butyl]-1H-pyrazol-4-ylamine |
1163253-70-0 |
C11H19N3O2 |
More |
| 1-[4-(2-methyl-[1,3]dioxolan-2-yl)-butyl]-4-nitro-1H-pyrazole |
1163253-69-7 |
C11H17N3O4 |
More |
| 1-[4-(2-methyl-[1,3]dioxolan-2-yl)-butyl]-3-nitro-1H-pyrazole |
1163253-74-4 |
C11H17N3O4 |
More |
| 8-Chloro-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepinehydrochloride |
956431-49-5 |
C8H9N2OCl.HCl |
More |
| 2,3,4,5-Tetrahydropyrido[3,2-f][1,4]oxazepine |
956461-77-1 |
C8H10N2O |
More |
| 8-Methyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepinehydrochloride |
956433-31-1 |
C9H12N2O.HCl |
More |
| 7-Bromo-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine |
1211579-13-3 |
C8H9N2OBr |
More |
| 8-Ethoxy-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine |
1154867-51-2 |
C10H14N2O2 |
More |
| Bis(3,5-bis(trifluoromethyl)phenyl)(2,4,6-triisopropyl-3,6-dimethoxy-[ |
1160861-60-8 |
C39H37F12O2P |
More |
| 1-(2-(indolin-1-yl)ethyl)-1H-pyrazol-4-amine |
1281758-09-5 |
C13H16N4 |
More |
